Hospital trust to launch endometriosis study

A doctor teams up with NBC News to fact-check viral health hacks circulating on TikTok—think "lemon water detoxes" or "ice face masks for weight loss." They’re digging into whether these trends hold up to science or if they’re just clickbait wrapped in wellness aesthetics.

Editor’s Note: Let’s be real—TikTok health trends spread faster than a cold in a kindergarten, but blindly following them can range from harmless to downright risky. This story cuts through the noise, giving you a doctor’s take on what’s legit and what’s just social media fluff. It matters because your health isn’t a trend, and it’s worth knowing what actually works.

Susan Monarez is stepping into her role as the new C.D.C. director at one of the agency's most turbulent moments. She’s staring down a perfect storm of challenges—budget cuts, layoffs, political pressure, and a boss (likely the president or health secretary) pushing for major changes in how public health operates. Her confirmation hearing last month was just the beginning; now comes the hard part.

Editor’s Note: The C.D.C. is a cornerstone of America’s health infrastructure, and its effectiveness impacts everything from disease outbreaks to everyday wellness programs. If Monarez can’t navigate these hurdles, it could weaken the agency’s ability to protect public health—especially after years of pandemic-fueled scrutiny. This isn’t just bureaucratic drama; it’s about whether the U.S. can maintain trust in its health leadership.

NRS Healthcare, a major supplier of wheelchairs, hoists, and other essential medical equipment in the UK, is reportedly about to collapse due to running out of cash by the end of the week. This could leave many patients and caregivers scrambling for alternatives.

Nearly twenty vaccine experts who were recently removed from a key U.S. advisory committee are sounding the alarm, claiming the panel is drifting away from strict scientific standards. They’re worried that politics or other pressures might be undermining the group’s credibility—and, by extension, public trust in vaccines.

Editor’s Note: When top scientists start saying a major health advisory body is cutting corners, it’s a big deal. Vaccines are already a touchy subject for many people, and if the experts who shape recommendations don’t trust the process, it could fuel even more skepticism. This isn’t just insider drama—it’s about whether the public can feel confident in the shots they’re told to get.

This piece is a quick rundown of the latest buzz in the health care sector, spotlighting big players like AstraZeneca, Philips, and Raffles Medical Group. Think of it as a snapshot of who’s up, who’s down, and what’s driving the chatter in the industry right now—whether it’s drug developments, tech innovations, or financial moves.